SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 2014 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (233)2/13/2014 1:06:24 AM
From: BulbaMan  Respond to of 487
 
Rick: Coincidentally, I just posted some of the same Shkreli tweets on Dew’s iHub board.
Peace & good health,
Bulba



To: scaram(o)uche who wrote (233)2/13/2014 8:39:49 AM
From: rkrw  Respond to of 487
 
That report of the patients taking PKAN.....

This is what Peter posted on another board (and I concur).

I have to believe the following article is totally bogus:

benzinga.com

Either it is a deliberate pump or someone got very confused indeed about the right disease or the right drug. No way seven patients could already be dosed - as far as I know there has been no announcement that the drug is in the clinic at all.

Peter



To: scaram(o)uche who wrote (233)2/13/2014 9:21:01 AM
From: scaram(o)uche  Read Replies (1) | Respond to of 487
 
>> plan may be to remove it from the market for gallstones and pursue the CTX orphan designation with an IND? <<

Yup. Sort of ironic, given QCOR.

Thanks, Jim/Peter. Wasn't mentioned (PKAN) and hadn't moved share price, so....

;-)

And thanks again, Jim, for leading so many of us to this cash machine.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News